ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

HQL // abrdn Life Sciences Investors

ANR <GO> NYSE RQD COCKPIT → CIK 0000884121 ↗
Financials • Investment Managers
$18.74 ▲ +0.46 (+2.52%)
MKT CAP: $481.2M • VOL: 102.9K
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8 SELL: 2
12M STREET TARGET RANGE IMPLIED: +14.0%
LOW
$16
MEDIAN
$21
MEAN
$21
HIGH
$25
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100 EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE HQL TAPE
HQL // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>) CURRENT 90D STREET CONSENSUS
INSTITUTION / ANALYST ACTION RATING TARGET PRIOR PT CALL DATE PX AT CALL RET SINCE CALL 1Y ACCURACY BS GRADE
Morgan Stanley Institutional
Equity Desk
REITERATE OUTPERFORM $22.68 $21.55 2025-02-14 $17.05 +9.9% 78% A
Goldman Sachs Global Research
Sector Coverage
TARGET REV STRONG BUY $23.61 $22.11 2025-02-06 $17.62 +6.4% 74% A
J.P. Morgan Securities
US Large Cap
REITERATE BUY $21.36 $20.61 2025-01-29 $17.99 +4.2% 67% B
Bernstein Autonomous
Forensic Coverage
INITIATE HOLD $19.11 — 2025-01-17 $18.37 +2.0% 61% B
Barclays Capital
Americas Research
DOWNGRADE UNDERPERFORM $16.49 $17.80 2025-01-09 $16.68 -11.2% 42% D
UBS Investment Bank
Institutional Desk
UPGRADE BUY $22.30 $19.49 2024-12-18 $16.30 +14.9% 72% A
Citigroup Global Markets
Sector Lead
TARGET REV HOLD $18.18 $18.93 2024-12-04 $17.43 -4.3% 48% C